市場調査レポート
商品コード
1351032
整形外科用インプラントの世界市場:2023-2030年Global Orthopedic Implants Market 2023-2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
整形外科用インプラントの世界市場:2023-2030年 |
出版日: 2023年09月11日
発行: Orion Market Research
ページ情報: 英文 125 Pages
納期: 2~3営業日
|
整形外科用インプラントの世界市場は、予測期間中にCAGR 5.0%の大幅な成長が見込まれています。市場の成長は、高齢化人口の増加、整形外科疾患の有病率の上昇、医療技術の進歩、整形外科手術件数の増加などの要因に起因しています。さらに、より良い生活の質を求める需要や低侵襲手術の採用は、整形外科インプラントの需要を促進すると予想される要因の一部です。さらに、スポーツによる怪我は整形外科用インプラントの需要を大きく牽引し、インプラント技術の進歩や低侵襲手術の開発につながっています。関節置換術、特に膝と股関節の置換術は、スポーツ傷害の影響を受ける一般的な処置です。インプラントの受け入れ拡大、ヘルスケア支出の増加、新興市場におけるスポーツ文化の拡大は、整形外科インプラント市場の成長をさらに促進しています。
製品タイプ別では、脊椎インプラントのサブセグメントが予測期間中に大きな成長を記録すると予測されています。同分野の成長の主な要因は、人口の高齢化や脊椎障害・損傷の有病率の増加などです。United Spinal Associationによると、毎年約17,700人のアメリカ人が脊髄損傷を受けています。およそ78%が男性で、平均年齢は43歳です。脊髄損傷のほとんどは、自動車事故(39.3%)、次いで転倒(31.8%)、暴力(13.2%)、スポーツ(8%)、医療・外科処置(4.3%)です。市場はまた、研究開発や新製品・ソリューションの発売といった要因にも影響されます。脊椎整形外科製品を提供する主要企業には、メドトロニック、デピュー・シンセ、ストライカー・コーポレーション、ジマー・バイオメット、グローバス・メディカルなどがあります。
整形外科用インプラントの世界市場は、北米(米国とカナダ)、欧州(イタリア、スペイン、ドイツ、フランス、その他)、アジア太平洋(インド、中国、日本、韓国、その他)、世界のその他の地域(中東とアフリカ、ラテンアメリカ)など、地域別にさらに細分化されています。市場は、要求に応じて特定の地域または国レベルで分析することができます。なかでも、欧州市場は予測期間中に顕著な成長を遂げると予測されています。しかし、アジア太平洋地域は整形外科インプラント市場でかなりの成長を遂げると予測されています。
これらの地域の中で、北米地域は予測期間中に整形外科インプラント市場で大きなシェアを占めると予測されています。同地域における整形外科インプラント市場の成長は、整形外科疾患の有病率の高さ、整備されたヘルスケアインフラ、先進的な整形外科インプラントの採用増加といった要因が主な要因となっています。例えば、2022年8月、OSSIO, Inc.は、米国でOSSIOfiber(R)Suture Anchorsを発売し、商業的に使用しています。OSSIOfiber(R)Suture Anchorsは、縫合糸を骨に固定するための皮質骨よりも強い独自のインプラント材料です。この素材は、有害な生物学的反応を起こすことなく、迅速な骨の新生と一体化を可能にし、様々な外科的応用が可能です。
Title: Global Orthopedic Implants Market Size, Share & Trends Analysis Report by Product Type (Reconstructive Joint Replacements, Spinal Implants, Dental Implants, Trauma, Orthobiologics, and Others), by Biomaterial (Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials, and Others), and by Type (Knee, Hip, Wrist and Shoulder, Dental, Spine, and Others)Forecast Period (2023-2030).
The global orthopedic implants market is anticipated to grow at a considerable CAGR of 5.0% during the forecast period. The growth of the market is attributed to factors such as an increasing aging population, rising prevalence of orthopedic conditions, advancements in medical technologies, and a growing number of orthopedic surgeries. Further, the demand for better quality of life and the adoption of minimally invasive surgical procedures are some of the factors anticipated to fuel the demand for Orthopedic Implants. Moreover, sports injuries are a significant driver of demand for orthopedic implants, leading to advancements in implant technology and the development of minimally invasive procedures. Joint replacements, especially knee and hip replacements, are common procedures influenced by sports injuries. The growing acceptance of implants, increased healthcare spending, and expanding sports culture in emerging markets further enhance the orthopedic implant market's growth.
The global orthopedic implants market is segmented based on its Product Type, Biomaterial, and Type. Based on its Product Type, the market is segmented into Reconstructive Joint Replacements, Spinal Implants, Dental Implants, Trauma, Orthobiologics, and Others. Based on Biomaterial, the market is categorized into Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials, and Others. Further, based on Type, the market is segmented into Knee, Hip, Wrist and Shoulder, Dental, Spine, and Others. Among the segments, Reconstructive Joint Replacements are anticipated to hold a prominent market share.
Among the product type segment, the spinal implants sub-segment is anticipated to register significant growth for the forecast period. The growth of the segment is primarily attributed to factors such as an aging population and the increasing prevalence of spinal disorders and injuries. According to the United Spinal Association, approximately 17,700 Americans acquire a spinal cord injury every year. Roughly 78% are men, and their average age is 43. Most spinal cord injuries happen as a result of a vehicle accident (39.3%), followed closely by falls (31.8%), trailed by violence (13.2%), sports (8%), and medical/surgical procedures (4.3%). The market is also influenced by factors such as research and development and the launches of new products and solutions. Some of the key players offering spine orthopedic products include Medtronic, DePuy Synthes, Stryker Corp., Zimmer Biomet, and Globus Medical, among others.
The global Orthopedic Implants market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among these, the Europe market is anticipated to cater to prominent growth over the forecast period. However, the Asia-Pacific region is projected to experience considerable growth in the Orthopedic Implants market.
Among these regions, the North America region is anticipated to account for a significant share in the Orthopedic Implants market during the forecast period. The growth of the Orthopedic Implants market in the region is primarily driven by factors such as a high prevalence of orthopedic disorders, well-established healthcare infrastructure, and increasing adoption of advanced orthopedic implants. For instance, in August 2022, OSSIO, Inc. launched and commercially used OSSIOfiber® Suture Anchors in the US, a unique implant material stronger than cortical bone for fixation of suture to bone. The material allows for rapid bone in-growth and integration without adverse biological response, with various surgical applications available.
The major companies serving the global orthopedic implants market include: India Medtronic Pvt. Ltd., Medical Devices Business Services, Inc., Smith & Nephew plc, Stryker, and Zimmer Biomet, among others. The market players are considerably contributing to the market growth by adopting various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in February 2022, Smith+Nephew announced the launch of its CORI Surgical System in Japan. This next-generation robotics system is designed for robotic-assisted surgery in the orthopedic market. The launch comes at a time when the demand for robotic-assisted surgery in Japan is expected to grow significantly. The CORI Surgical System expands the capabilities of Smith+Nephew's robotics platform and includes total hip arthroplasty. The system was approved by the FDA in 2020 and is the successor to the NAVIO platform.